Janney Montgomery Scott’s AbbVie ABBV Stock Holding History

Janney Montgomery Scott’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$263M	Buy	1,207,278 +124,417	+11%	+$27.6M	0.65%	22
2025 Q4	$247M	Buy	1,082,861 +122,703	+13%	+$28M	0.57%	32
2025 Q3	$222M	Buy	960,158 +21,229	+2%	+$4.32M	0.53%	34
2025 Q2	$174M	Buy	938,929 +11,205	+1%	+$2.08M	0.46%	39
2025 Q1	$194M	Sell	927,724 -28,832	-3%	-$5.61M	0.55%	34
2024 Q4	$170M	Buy	956,556 +25,246	+3%	+$4.64M	0.47%	38
2024 Q3	$184M	Sell	931,310 -15,395	-2%	-$2.87M	0.51%	37
2024 Q2	$162M	Sell	946,705 -42,045	-4%	-$6.96M	0.5%	39
2024 Q1	$180M	Buy	988,750 +17,957	+2%	+$3.09M	0.54%	32
2023 Q4	$150M	Buy	970,793 +42,242	+5%	+$6.16M	0.49%	35
2023 Q3	$138M	Buy	928,551 +594	+0.1%	+$87.2K	0.52%	38
2023 Q2	$125M	Sell	927,957 -25,696	-3%	-$3.77M	0.44%	47
2023 Q1	$152M	Sell	953,653 -65,672	-6%	-$10M	0.62%	30
2022 Q4	$165M	Buy	1,019,325 +47,753	+5%	+$7.32M	0.64%	27
2022 Q3	$130M	Buy	971,572 +39,093	+4%	+$5.61M	0.56%	32
2022 Q2	$142M	Buy	932,479 +33,505	+4%	+$5.12M	0.64%	28
2022 Q1	$146M	Buy	898,974 +3,978	+0.4%	+$578K	0.62%	28
2021 Q4	$121M	Buy	894,996 +37,253	+4%	+$4.4M	0.47%	45
2021 Q3	$92.5M	Buy	857,743 +41,195	+5%	+$4.71M	0.4%	56
2021 Q2	$92M	Buy	816,548 +10,430	+1%	+$1.17M	0.41%	57
2021 Q1	$87.2M	Buy	806,118 +93,340	+13%	+$9.98M	0.42%	56
2020 Q4	$76.4M	Buy	712,778 +17,049	+2%	+$1.64M	0.37%	63
2020 Q3	$60.9M	Buy	695,729 +40,222	+6%	+$3.79M	0.35%	66
2020 Q2	$64.4M	Buy	655,507 +38,318	+6%	+$3.37M	0.41%	54
2020 Q1	$47M	Buy	617,189 +28,433	+5%	+$2.42M	0.37%	60
2019 Q4	$52.1M	Buy	588,756 +23,796	+4%	+$1.98M	0.34%	64
2019 Q3	$42.8M	Buy	564,960 +38,390	+7%	+$2.63M	0.31%	79
2019 Q2	$38.3M	Buy	526,570 +55,014	+12%	+$4.32M	0.29%	79
2019 Q1	$38M	Buy	471,556 +1,311	+0.3%	+$107K	0.31%	73
2018 Q4	$43.4M	Sell	470,245 -34,755	-7%	-$3.06M	0.42%	52
2018 Q3	$47.8M	Sell	505,000 -3,687	-0.7%	-$350K	0.41%	52
2018 Q2	$47.1M	Buy	508,687 +3,230	+0.6%	+$315K	0.45%	47
2018 Q1	$47.8M	Sell	505,457 -30,748	-6%	-$3.38M	0.48%	42
2017 Q4	$51.9M	Sell	536,205 -17,069	-3%	-$1.61M	0.54%	33
2017 Q3	$49.2M	Buy	553,274 +16,362	+3%	+$1.25M	0.56%	31
2017 Q2	$38.9M	Buy	536,912 +3	+0%	+$202	0.49%	41
2017 Q1	$35M	Buy	536,909 +63,700	+13%	+$4M	0.47%	43
2016 Q4	$29.6M	Sell	473,209 -13,199	-3%	-$806K	0.45%	49
2016 Q3	$30.7M	Buy	+486,408	New	+$31.5M	0.54%	37
2016 Q1	–	Sell	-294,320	Closed	-$17.4M	–	1263
2015 Q4	$17.4M	Buy	294,320 +14,105	+5%	+$812K	0.45%	48
2015 Q3	$15.2M	Buy	+280,215	New	+$18.2M	0.43%	52
2015 Q2	–	Sell	-237,072	Closed	-$13.9M	–	2020
2015 Q1	$13.9M	Buy	237,072 +30,919	+15%	+$1.87M	0.26%	77
2014 Q4	$13.5M	Sell	206,153 -2,629	-1%	-$166K	0.27%	69
2014 Q3	$12.1M	Buy	208,782 +44,630	+27%	+$2.48M	0.25%	77
2014 Q2	$9.26M	Sell	164,152 -30,868	-16%	-$1.62M	0.2%	110
2014 Q1	$10M	Sell	195,020 -6,620	-3%	-$335K	0.24%	86
2013 Q4	$10.6M	Buy	201,640 +7,302	+4%	+$359K	0.28%	65
2013 Q3	$8.69M	Buy	194,338 +54,050	+39%	+$2.4M	0.26%	79
2013 Q2	$5.8M	Buy	+140,288	New	+$6.14M	0.61%	31

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janney Montgomery Scott's ABBV Position: Q1 2026 in Review

Janney Montgomery Scott increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $27.6M and bringing the position to 1,207,278 shares worth $263M. The position accounts for 0.65% of the portfolio, ranked #22.

Janney Montgomery Scott first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Janney Montgomery Scott held 1,207,278 shares of AbbVie worth $263M as of Q1 2026.
Janney Montgomery Scott bought 124,417 AbbVie shares in Q1 2026, an estimated $27.6M.
AbbVie made up 0.65% of Janney Montgomery Scott's portfolio in Q1 2026, its #22 holding.
Janney Montgomery Scott first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.